ARTICLE | Financial News
Tvax Biomedical amends IPO
January 30, 2012 8:00 AM UTC
Tvax Biomedical Inc., Lenexa, Kan. Business: Cancer, Infectious Date announced: 1/23/12 Type: IPO To be raised: Up to $25.3 million Shares: 2 million Price: $9-$11 Underwriters: Roth Capital Partners;...